Agreement strengthens Aurigene's discovery platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and BANGALORE, India, May 13, 2026 /PRNewswire/ -- ERS Genomics Limi… For the full story, visit the source.
TechnologyKarnataka
ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery
Agreement strengthens Aurigene's discovery platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and BANGALORE, India, May 13, 2026 /PRNewswire/ -- ERS Genomics Limi…
PRNewswire· 5 months ago· 2 min read
This summary is sourced from PRNewswire. Read the full article at:PRNewswire